These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33406577)

  • 1. SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia.
    Chen W; Zhang J; Qin X; Wang W; Xu M; Wang LF; Xu C; Tang S; Liu P; Zhang L; Liu X; Zhang Y; Yi C; Hu Z; Yi Y
    Biomed Pharmacother; 2020 Oct; 130():110629. PubMed ID: 33406577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
    Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
    JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing Antibody Responses to SARS-CoV-2 in Korean Patients Who Have Recovered from COVID-19.
    Kim YJ; Bae JY; Bae S; Hwang S; Kwon KT; Chang HH; Lee WK; Cui C; Lee GE; Kim SW; Park MS
    Yonsei Med J; 2021 Jul; 62(7):584-592. PubMed ID: 34164955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India.
    Shrivastava S; Palkar S; Shah J; Rane P; Lalwani S; Mishra AC; Arankalle VA
    Am J Trop Med Hyg; 2021 Jun; 105(2):401-406. PubMed ID: 34138748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    Karuna S; Li SS; Grant S; Walsh SR; Frank I; Casapia M; Trahey M; Hyrien O; Fisher L; Miner MD; Randhawa AK; Polakowski L; Kublin JG; Corey L; Montefiori D;
    PLoS Med; 2021 Dec; 18(12):e1003868. PubMed ID: 34871308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Shedding of SARS-CoV-2 Virus in COVID-19 Patients and Neutralizing Antibody Level].
    Ayhancı T; Toptan H; Özer YE; Uzar S; Enül H; Adıay C; Sarac F; Dheir H; Köroğlu M; Hasöksüz M; Altındiş M
    Mikrobiyol Bul; 2022 Jul; 56(3):416-431. PubMed ID: 35960235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T
    J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and Clinical Factors at Admission Affect the Levels of Neutralizing Antibodies Six Months after Recovering from COVID-19.
    Li X; Pang L; Yin Y; Zhang Y; Xu S; Xu D; Shen T
    Viruses; 2022 Jan; 14(1):. PubMed ID: 35062284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    Kalkan Yazıcı M; Koç MM; Çetin NS; Karaaslan E; Okay G; Durdu B; Sümbül B; Doymaz MZ
    J Immunol; 2020 Nov; 205(10):2719-2725. PubMed ID: 32978281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.
    Xu X; Nie S; Wang Y; Long Q; Zhu H; Zhang X; Sun J; Zeng Q; Zhao J; Liu L; Li L; Huang A; Hou J; Hou FF
    Signal Transduct Target Ther; 2021 May; 6(1):197. PubMed ID: 34006847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections.
    Wendel S; Fontão-Wendel R; Fachini R; Candelaria G; Scuracchio P; Achkar R; Brito M; Reis LF; Camargo A; Amano M; Machado R; Araujo D; Soares C; Durigon E
    Transfusion; 2021 May; 61(5):1447-1460. PubMed ID: 33604884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High neutralizing antibody titer in intensive care unit patients with COVID-19.
    Liu L; To KK; Chan KH; Wong YC; Zhou R; Kwan KY; Fong CH; Chen LL; Choi CY; Lu L; Tsang OT; Leung WS; To WK; Hung IF; Yuen KY; Chen Z
    Emerg Microbes Infect; 2020 Dec; 9(1):1664-1670. PubMed ID: 32618497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects.
    Cristiano A; Nuccetelli M; Pieri M; Sarubbi S; Pelagalli M; Calugi G; Tomassetti F; Bernardini S
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108215. PubMed ID: 34649115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
    Goodhue Meyer E; Simmons G; Grebe E; Gannett M; Franz S; Darst O; Di Germanio C; Stone M; Contestable P; Prichard A; Reik R; Vassallo R; Young P; Busch MP; Williamson P; Dumont LJ
    Transfusion; 2021 Apr; 61(4):1160-1170. PubMed ID: 33554362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
    Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
    Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Kimura M; Yamada H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Kawago K; Fukui Y; Sakamaki I; Yamamoto Y
    Sci Rep; 2021 Aug; 11(1):16535. PubMed ID: 34400739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic Characteristics of Neutralizing Antibody Responses Vary among Patients with COVID-19.
    Li LH; Tu HW; Liang D; Wen CY; Li AA; Lin WY; Hu KQ; Hong WS; Li YP; Su J; Zhao ST; Li W; Yuan RY; Zhou PP; Hu FY; Tang XP; Ke CW; Ke BX; Cai WP
    Biomed Environ Sci; 2021 Dec; 34(12):976-983. PubMed ID: 34981720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2.
    Favresse J; Gillot C; Di Chiaro L; Eucher C; Elsen M; Van Eeckhoudt S; David C; Morimont L; Dogné JM; Douxfils J
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
    Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
    J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.